Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease
2021; Wiley; Volume: 36; Issue: 12 Linguagem: Inglês
10.1002/mds.28803
ISSN1531-8257
AutoresŁukasz Milanowski, Olajumoke Oshinaike, Ronald L. Walton, Alexandra I. Soto‐Beasley, Rana Hanna Al‐Shaikh, Audrey Strongosky, Owen A. Ross, Zbigniew K. Wszołek, Shamsideen Abayomi Ogun,
Tópico(s)RNA regulation and disease
ResumoMovement DisordersVolume 36, Issue 12 p. 2971-2973 Letters: New Observation Screening of GBA Mutations in Nigerian Patients with Parkinson's Disease Lukasz M. Milanowski MD, Lukasz M. Milanowski MD orcid.org/0000-0003-4197-8518 Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland These authors contributed equally.Search for more papers by this authorOlajumoke Oshinaike MD, Olajumoke Oshinaike MD Department of Clinical Genomics, Mayo Clinic, Jacksonville, Florida, USA These authors contributed equally.Search for more papers by this authorRonald L. Walton BS, Ronald L. Walton BS Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorAlexandra I. Soto-Beasley MS, Alexandra I. Soto-Beasley MS Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorRana Hanna Al-Shaikh MD, MS, Rana Hanna Al-Shaikh MD, MS Department of Neurology, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorAudrey J. Strongosky BS, CCRC, Audrey J. Strongosky BS, CCRC Department of Neurology, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorOwen A. Ross PhD, Corresponding Author Owen A. Ross PhD ross.owen@mayo.edu orcid.org/0000-0003-4813-756X Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA Division of Neurology, Lagos State University Teaching Hospital, Lagos, Nigeria Correspondence to: Dr. Shamsideen Abayomi Ogun, Division of Neurology, Lagos State University College of Medicine/Teaching Hospital, PMB 21266 Ikeja, Lagos, Nigeria, E-mail: yomiogun2002@yahoo.com; Dr. Owen A. Ross, Department of Neuroscience, Mayo Clinic Jacksonville,4500 San Pablo Road, Jacksonville, FL 32224, USA, E-mail: ross.owen@mayo.eduSearch for more papers by this authorZbigniew K. Wszolek MD, Zbigniew K. Wszolek MD Department of Neurology, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorShamsideen Abayomi Ogun MD, Corresponding Author Shamsideen Abayomi Ogun MD yomiogun2002@yahoo.com Department of Clinical Genomics, Mayo Clinic, Jacksonville, Florida, USA Correspondence to: Dr. Shamsideen Abayomi Ogun, Division of Neurology, Lagos State University College of Medicine/Teaching Hospital, PMB 21266 Ikeja, Lagos, Nigeria, E-mail: yomiogun2002@yahoo.com; Dr. Owen A. Ross, Department of Neuroscience, Mayo Clinic Jacksonville,4500 San Pablo Road, Jacksonville, FL 32224, USA, E-mail: ross.owen@mayo.eduSearch for more papers by this author Lukasz M. Milanowski MD, Lukasz M. Milanowski MD orcid.org/0000-0003-4197-8518 Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland These authors contributed equally.Search for more papers by this authorOlajumoke Oshinaike MD, Olajumoke Oshinaike MD Department of Clinical Genomics, Mayo Clinic, Jacksonville, Florida, USA These authors contributed equally.Search for more papers by this authorRonald L. Walton BS, Ronald L. Walton BS Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorAlexandra I. Soto-Beasley MS, Alexandra I. Soto-Beasley MS Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorRana Hanna Al-Shaikh MD, MS, Rana Hanna Al-Shaikh MD, MS Department of Neurology, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorAudrey J. Strongosky BS, CCRC, Audrey J. Strongosky BS, CCRC Department of Neurology, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorOwen A. Ross PhD, Corresponding Author Owen A. Ross PhD ross.owen@mayo.edu orcid.org/0000-0003-4813-756X Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA Division of Neurology, Lagos State University Teaching Hospital, Lagos, Nigeria Correspondence to: Dr. Shamsideen Abayomi Ogun, Division of Neurology, Lagos State University College of Medicine/Teaching Hospital, PMB 21266 Ikeja, Lagos, Nigeria, E-mail: yomiogun2002@yahoo.com; Dr. Owen A. Ross, Department of Neuroscience, Mayo Clinic Jacksonville,4500 San Pablo Road, Jacksonville, FL 32224, USA, E-mail: ross.owen@mayo.eduSearch for more papers by this authorZbigniew K. Wszolek MD, Zbigniew K. Wszolek MD Department of Neurology, Mayo Clinic, Jacksonville, Florida, USASearch for more papers by this authorShamsideen Abayomi Ogun MD, Corresponding Author Shamsideen Abayomi Ogun MD yomiogun2002@yahoo.com Department of Clinical Genomics, Mayo Clinic, Jacksonville, Florida, USA Correspondence to: Dr. Shamsideen Abayomi Ogun, Division of Neurology, Lagos State University College of Medicine/Teaching Hospital, PMB 21266 Ikeja, Lagos, Nigeria, E-mail: yomiogun2002@yahoo.com; Dr. Owen A. Ross, Department of Neuroscience, Mayo Clinic Jacksonville,4500 San Pablo Road, Jacksonville, FL 32224, USA, E-mail: ross.owen@mayo.eduSearch for more papers by this author First published: 29 September 2021 https://doi.org/10.1002/mds.28803 Relevant conflicts of interest/financial disclosures:: Mayo Clinic is an American Parkinson Disease Association (APDA) Mayo Clinic Information and Referral Center, an APDA Center for Advanced Research, and the Mayo Clinic Lewy Body Dementia Association Research Center of Excellence. L.M.M. is supported by the Polish National Agency for Academic Exchange Iwanowska's Fellowship PPN/IWA/2018/1/00006/U/00001/01. Z.K.W. is partially supported by the Mayo Clinic Center for Regenerative Medicine, Mayo Clinic in Florida Focused Research Team Program, the gifts from The Sol Goldman Charitable Trust, the Donald G. and Jodi P. Heeringa Family, the Haworth Family Professorship in Neurodegenerative Diseases fund, and The Albertson Parkinson's Research Foundation. He serves as principal investigator or co–principal investigator on Biohaven Pharmaceuticals, Inc. (BHV4157-206 and BHV3241-301) and Neuraly, Inc. (NLY01-PD-1) grants and as external advisory board member for the Vigil Neuroscience, Inc. He serves as co–principal investigator of the Mayo Clinic APDA Center for Advanced Research. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume36, Issue12December 2021Pages 2971-2973 RelatedInformation
Referência(s)